[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Endoscopic screening and risk of colorectal cancer according to type 2 diabetes status
In short, GLP-1 does everything a diabetes drug should do
Instead, theyre marketed as over-the-counter support supplements
Future studies are needed to determine if other samples of individuals using a GLP-1RA medications find similar HEI score and intervention studies to explore ways to improve dietary quality and optimize nutrient intake and timing while also assessing the impact on health outcomes